Occasionally, someone might experience headaches or cramping, though this is uncommon
Risks of Concomitant Use or Discontinuation of Cytochrome P450 3A4 Inhibitors and Inducers Concomitant use of hydrocodone bitartrate and acetaminophen tablets with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of hydrocodone bitartrate and acetaminophen tablets and prolong opioid adverse reactions, which may cause potentially fatal respiratory depression [see WARNINGS], particularly when an inhibitor is added after a stable dose of hydrocodone bitartrate and acetaminophen tablets is achieved
Low B12 levels are increasingly common, especially in people following vegan or vegetarian diets, those with absorption issues, or individuals experiencing tiredness, low mood, or brain fog
After semaglutide and tirzepatide were placed on the FDA drug shortage list, Neumiller said many companies saw an opportunity to distribute off-brand forms of the drugs due to high demand
